Germany's Merck KGaA Swoops In With $11.3 Billion Medtech Buyout

BREAKING: S&P 500 Closes Just Below Key Level In Divergent Week

Germany's Merck KGaA pledged Thursday to buy Bio-Techne (TECH) for $11.3 billion. The deal expands its portfolio of reagents, life sciences tools and diagnostic products. Bio-Techne stock rocketed 20.1% to 70.70, approaching the deal price of $73 per share. That price tag is a 36% premium to the stock's one-month volume-weighted average trading price, the companies said in a news…

Copyright ©2026 Investor's Business Daily, LLC. All rights reserved. 87990cbe856818d5eddac44c7b1cdeb8

2/04/2026 A Relative Strength Rating upgrade for Bio-Techne shows improving technical performance. Will it continue?

2/04/2026 A Relative Strength Rating upgrade for Bio-Techne shows improving technical...

Get instant access to exclusive stock lists, expert market analysis and powerful tools with 2 months of IBD Digital for only $20!

Get market updates, educational videos, webinars, and stock analysis.

Learn how you can make more money with IBD's investing tools, top-performing stock lists, and educational content.

Fuente original: Yahoo Finance (https://www.investors.com/news/technology/bio-techne-merck-kgaa-takeover-bid/?src=A00220&yptr=yahoo)